These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31492625)

  • 1. An Updated Meta-analysis of Radial versus Femoral Access for Percutaneous Coronary Intervention in the Context of Aggressive Bleeding Avoidance Strategies.
    Shah R; Khan S; Rashid A; Siddiqui T; Nayyar M
    Cardiovasc Revasc Med; 2020 Feb; 21(2):242-244. PubMed ID: 31492625
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between arterial access site and anticoagulation strategy on major bleeding and mortality: A historical cohort analysis in the Veteran population.
    Bagai J; Little B; Banerjee S
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):95-101. PubMed ID: 28624360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
    Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Use of Bivalirudin and Radial Access in Acute Coronary Syndromes Is Not Superior to the Use of Either One Separately: Meta-Analysis of Randomized Controlled Trials.
    Mina GS; Gobrial GF; Modi K; Dominic P
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1523-31. PubMed ID: 27491601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Use and Impact of Bleeding Avoidance Strategies on Percutaneous Coronary Intervention-Related Bleeding Stratified by Predicted Risk.
    Gluckman TJ; Wang L; Spinelli KJ; Petersen JL; Huang P; Amin A; Messenger JC; Rao SV
    Circ Cardiovasc Interv; 2020 Jun; 13(6):e008702. PubMed ID: 32527190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Verdoia M; Barbieri L; Parodi G; Bellandi B; Schaffer A; Suryapranata H; De Luca G
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):553-565. PubMed ID: 28471057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of radial versus femoral access site on coronary angiography and intervention outcomes: A systematic review and meta-analysis.
    Brener MI; Bush A; Miller JM; Hasan RK
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1093-1104. PubMed ID: 28544320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
    Khambatta S; Othman H; Seth M; Lalonde T; Rosman HS; Gurm HS; Mehta RH;
    Cardiovasc Revasc Med; 2016 Jun; 17(4):233-40. PubMed ID: 26994504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial.
    Hamon M; Rasmussen LH; Manoukian SV; Cequier A; Lincoff MA; Rupprecht HJ; Gersh BJ; Mann T; Bertrand ME; Mehran R; Stone GW
    EuroIntervention; 2009 May; 5(1):115-20. PubMed ID: 19577992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of operator radiation exposure comparing transradial and transfemoral approach for percutaneous coronary procedures: rationale and design of the minimizing adverse haemorrhagic events by TRansradial access site and systemic implementation of angioX - RAdiation Dose study (RAD-MATRIX).
    Sciahbasi A; Calabrò P; Sarandrea A; Rigattieri S; Tomassini F; Sardella G; Zavalloni D; Cortese B; Limbruno U; Tebaldi M; Gagnor A; Rubartelli P; Zingarelli A; Valgimigli M
    Cardiovasc Revasc Med; 2014 Jun; 15(4):209-13. PubMed ID: 24746599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis.
    Olmedo W; Villablanca PA; Sanina C; Walker J; Weinreich M; Brevik J; Avendano R; Bravo CA; Romero J; Ramakrishna H; Babaev A; Attubato M; Hernandez-Suarez DF; Cox-Alomar P; Pyo R; Krishnan P; Wiley J
    Vascular; 2019 Feb; 27(1):78-89. PubMed ID: 30501582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention.
    Shah R; Jovin IS; Chaudhry A; Haji SA; Askari R; Dennis MM; Berzingi C; Rao SV
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):241-247. PubMed ID: 30269393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis.
    Lipinski MJ; Lee RC; Gaglia MA; Torguson R; Garcia-Garcia HM; Pichard AD; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2016 Dec; 17(8):535-545. PubMed ID: 27842901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
    Ortiz D; Singh M; Jahangir A; Allaqaband S; Khitha J; Bajwa TK; Mewissen MW
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):408-413. PubMed ID: 27526661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Wang Y; Zhao HW; Wang CF; Fan CY; Zhang XJ; Zhu Y; Luo DF; Yu GN; Hou AJ; Luan B
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):825-831. PubMed ID: 30724035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Shah R; Matin K; Rogers KC; Rao SV
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):196-204. PubMed ID: 27862911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials.
    Ferrante G; Rao SV; Jüni P; Da Costa BR; Reimers B; Condorelli G; Anzuini A; Jolly SS; Bertrand OF; Krucoff MW; Windecker S; Valgimigli M
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1419-34. PubMed ID: 27372195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.